Tag: Stability Testing in Novel Packaging

How to Apply ICH Q1A(R2) Guidelines for Stress Testing Implementing ICH Q1A(R2) Guidelines for Stress Testing of Drug Substances and Products Introduction Stress testing is a critical part of stability studies designed to identify the degradation products and understand the intrinsic stability of a drug substance or product. The ICH Q1A(R2) guidelines provide specific recommendations…

Read More “How to Apply ICH Q1A(R2) Guidelines for Stress Testing” »

How to Conduct Stability Studies for Biosimilars as per EMA Guidelines Guidelines for Stability Testing of Biosimilars in Compliance with EMA Introduction Biosimilars are biological medicines highly similar to an already approved biological reference product. Conducting stability studies for biosimilars is crucial to demonstrate that they maintain the same quality, safety, and efficacy as their…

Read More “How to Conduct Stability Studies for Biosimilars as per EMA Guidelines” »

How to Implement Stability Testing for Orphan Drugs Under US FDA Guidelines Guidelines for Stability Testing of Orphan Drugs in Compliance with US FDA Introduction Orphan drugs, which are intended to treat rare diseases, have unique regulatory requirements, including stability testing to ensure they meet quality, safety, and efficacy standards. The US FDA provides specific…

Read More “How to Implement Stability Testing for Orphan Drugs Under US FDA Guidelines” »

How to Apply FDA Guidance for Industry on Drug Product Stability Testing Implementing FDA Guidance for Drug Product Stability Testing Introduction Drug product stability testing is essential for ensuring that a drug maintains its intended quality, safety, and efficacy throughout its shelf life. The US FDA provides detailed guidance for industry on conducting stability testing,…

Read More “How to Apply FDA Guidance for Industry on Drug Product Stability Testing” »

How to Conduct Stability Studies in Compliance with Japanese Regulatory Requirements (PMDA) Guidelines for Stability Testing in Accordance with PMDA Requirements Introduction Stability studies are essential for demonstrating that drug products meet quality, safety, and efficacy standards over their intended shelf life. The Pharmaceutical and Medical Devices Agency (PMDA) in Japan has specific guidelines for…

Read More “How to Conduct Stability Studies in Compliance with Japanese Regulatory Requirements (PMDA)” »

How to Manage Stability Testing of Post-Approval Changes According to US FDA Guidelines Conducting Stability Testing for Post-Approval Changes per FDA Guidelines Introduction After a drug product receives marketing approval, manufacturers may need to implement changes to the product or its manufacturing process, such as changes in formulation, packaging, or manufacturing site. The US FDA…

Read More “How to Manage Stability Testing of Post-Approval Changes According to US FDA Guidelines” »

How to Apply ICH Q1C Guidelines for Stability Testing of New Dosage Forms Implementing ICH Q1C Guidelines for Stability Testing of New Dosage Forms Introduction Stability testing is a vital process for establishing the shelf life and storage conditions of new dosage forms of existing drug substances. The ICH Q1C guideline provides specific instructions on…

Read More “How to Apply ICH Q1C Guidelines for Stability Testing of New Dosage Forms” »

How to Develop Stability Study Reports for ANDA Submissions Creating Stability Study Reports for ANDA Submissions: A Comprehensive Guide Introduction Stability study reports are a critical component of Abbreviated New Drug Application (ANDA) submissions to the US FDA, providing evidence that a generic drug product maintains the same quality, safety, and efficacy as its reference…

Read More “How to Develop Stability Study Reports for ANDA Submissions” »